About SynkroMax
SynkroMax is a Healthcare company based in Chennai (India) founded in 2009 by Arvind Kumar Chandak and C V Seshadri. Tissue engineered products and enzymes are manufactured for various industries. The company has 44 employees. Its chief executive, as recorded, is V Subramanian. Its Indian entity Synkromax Biotech Private Limited reported revenue of ₹17.03 Cr. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
SynkroMax was established in 2009 in Chennai, India, focusing on biotechnology manufacturing. Enzymes are produced for applications in textile, leather, food, tea, and pharmaceutical sectors. Teaching kits for molecular biology and immunology are offered, including agarose gel electrophoresis, restriction analysis, bacterial DNA isolation, transformation, PCR, and eukaryotic DNA isolation kits. Manufacturing facilities are certified under ISO 9001:2015 and by DSIR.
- Headquarters Chennai, India
- Employees 44
- Founders Arvind Kumar Chandak, C V Seshadri
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website synkromax.com
- Legal Name Synkromax Biotech Private Limited
- Date of Incorporation 11 Aug, 2009
- Jurisdiction Thirumazhisai, Tamil Nadu, India
- Annual Revenue₹17.03 Cr
FY 2024 · +15% YoY
- Net Profit₹56.6 Lakh
FY 2024 · 3% margin
- EBITDA₹2.66 Cr
FY 2024 · 16% margin
- Employee Count44
Associated legal entities of SynkroMax
SynkroMax operates through Synkromax Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synkromax Biotech Private Limited CIN U74999TN2009PTC072537 | Active | 11 Aug 2009 | Thirumazhisai, Tamil Nadu | ₹17.0 Cr | 44 | 2 | View details |
Board of directors of Synkromax Biotech Private Limited (SynkroMax)
Synkromax Biotech Private Limited is the primary company behind SynkroMax. The board of Synkromax Biotech Private Limited currently have 2 directors; the longest-serving is Subramanian Veluchamy, appointed in 2011. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subramanian Veluchamy DIN 03519504 | Managing Director | 09 May 2011 | 15 yrs 5 mo | Synkromax Biotech Private Limited |
| Usha Subramanian DIN 08122224 | Director | 20 Jul 2020 | 6 yrs 3 mo | Synkromax Biotech Private Limited |
People of SynkroMax
3 people are tracked at SynkroMax (3 in leadership); the tracked headcount is 44.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
C V Seshadri | Co-Founder | Leadership |
V Subramanian | CEO | Leadership |
Complete people profiles for SynkroMax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SynkroMax
Figures of Synkromax Biotech Private Limited, the primary company behind SynkroMax, for FY 2024. Revenue was ₹17.03 Cr (+15% year on year). Net profit was ₹56.6 Lakh (3% margin). EBITDA was ₹2.66 Cr (16% margin). Revenue has grown at a compounded annual rate of +10% over three years and -8% over five years.
- ₹17.03 CrRevenue · FY 2024 · +15% YoY
- ₹56.6 LakhNet profit · 3% margin
- ₹2.66 CrEBITDA · 16% margin
- ₹10.78 CrPaid-up capital
- 44Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- -8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Synkromax Biotech Private Limited are on its company page.
Detailed financial statements for SynkroMax
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SynkroMax
SynkroMax was founded in 2009.
SynkroMax is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
V Subramanian is the CEO of SynkroMax, as recorded in our data.
SynkroMax has 44 employees.
The primary company behind SynkroMax, Synkromax Biotech Private Limited, reported revenue of ₹17.03 Cr for FY 2024, up 15% year on year.
SynkroMax was established in 2009 in Chennai, India, focusing on biotechnology manufacturing. Enzymes are produced for applications in textile, leather, food, tea, and pharmaceutical sectors. Teaching kits for molecular biology and immunology are offered, including agarose gel electrophoresis, restriction analysis, bacterial DNA isolation, transformation, PCR, and eukaryotic DNA isolation kits. Manufacturing facilities are certified under ISO 9001:2015 and by DSIR.
SynkroMax operates through Synkromax Biotech Private Limited.
The legal entities of SynkroMax currently have 2 directors, including Usha Subramanian, Subramanian Veluchamy.